Jul 25, 2019 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen. Thank you for joining us today for the Gemphire-NeuroBo Pharmaceuticals joint conference call to discuss the proposed merger of Gemphire with NeuroBo Pharmaceuticals, as we announced in the press release yesterday afternoon.
I would now like to turn the call over to Steve Gullans, Chief Executive Officer of Gemphire. Please go ahead, sir.
Steven R. Gullans - Gemphire Therapeutics Inc. - CEO, President, Director, Principal Financial Officer & Principal Accounting Officer
Thank you, Kevin, and thank you all for joining us today. Please note, there are slides accompanying today's call. To access these, go to the Investors & Media section of the Gemphire or NeuroBo corporate websites. Look under Events and Presentations, and you'll find them. Joining me today is John Brooks, Chief Executive Officer of NeuroBo.
But before we begin, we advise that certain remarks that are made during this call will include remarks about future expectations, plans and prospects for NeuroBo and Gemphire, which constitutes
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc. - M&A Call Transcript
Jul 25, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers